Development and Assessment of a Novel Palmitoylation-Related lncRNA Signature for Prognosis and Immune Landscape in Hepatocellular Carcinoma
The nine-lncRNA signature exhibits robust predictive power for HCC prognosis and provides novel insights into the mechanisms of lncRNA-regulated palmitoylation in HCC development.
Authors
- Kai Hu
- Zhimin Li (ORCID: https://orcid.org/0000-0002-3576-6175)
- Jinfeng Qiu
- Liang Xian
- Yu Liu (ORCID: https://orcid.org/0000-0001-5996-0469)
- Zhilong He
- Sixuan Wu (ORCID: https://orcid.org/0000-0001-7690-723X)
- Jing Qin (ORCID: https://orcid.org/0000-0002-4477-3334)
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- First Affiliated Hospital of University of South China (CN)
- University of South China (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2025-10-27
- DOI
- https://doi.org/10.32604/or.2025.070567
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00